Summary

Report Overview
ADC drugs, also known as antibody drug coupling agents, work by coupling small molecule drugs with antibodies through linkers to form drugs. These drugs combine the high targeting ability of antibodies with the strong killing power of chemical drugs, and are considered the most promising next-generation antibody technology. To reduce research and development costs, most ADC drug development worldwide chooses outsourcing, leveraging CDMO companies to enter clinical and market more quickly. CDMO services refer to pharmaceutical and biotechnology companies outsourcing the research and production of their drugs or biological products to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its ability to customize and specialize, which can meet the specific needs of different customers at different stages.

One of the primary drivers of the ADC drug CDMO market is the increasing demand for targeted therapies, particularly in oncology. Cancer remains a leading cause of death globally, and the traditional methods of chemotherapy, while effective, often come with severe side effects that limit their use. ADCs, which combine the targeting ability of monoclonal antibodies with the potency of cytotoxic drugs, offer a more precise and effective treatment option. By delivering the toxic drug directly to cancer cells, ADCs minimize damage to healthy tissues, thereby reducing adverse effects.The demand for ADCs is expected to increase significantly due to their ability to treat a wide range of cancers, including breast cancer, leukemia, and lung cancer. As the pipeline for ADC drugs continues to expand, pharmaceutical companies are increasingly relying on CDMOs to support the development and manufacturing of these complex therapies.

The global ADC Drug CDMO Service market size was estimated at USD 2897.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global ADC Drug CDMO Service market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global ADC Drug CDMO Service market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the ADC Drug CDMO Service market.
Global ADC Drug CDMO Service Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lonza Group
Merck KGaA
WuXi XDC
Abbvie
Piramal Pharma Solutions
Catalent
Sterling Pharma Solutions
Axplora
Aji Bio-Pharma
BSP Pharmaceuticals
Cerbios-Pharma
Goodwin Biotechnology
TOT Biopharm
Huadong Medicine
Innovent Biologics
Shanghai Henlius Biotech

Market Segmentation (by Type)
Cleavable Linkers
Non-cleavable Linkers

Market Segmentation (by Application)
Small and Medium-sized Pharmaceutical Companies
Large Pharmaceutical Companies

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the ADC Drug CDMO Service Market
Overview of the regional outlook of the ADC Drug CDMO Service Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the ADC Drug CDMO Service Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of ADC Drug CDMO Service, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

ページTOPに戻る

Table of Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of ADC Drug CDMO Service
1.2 Key Market Segments
1.2.1 ADC Drug CDMO Service Segment by Type
1.2.2 ADC Drug CDMO Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADC Drug CDMO Service Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADC Drug CDMO Service Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global ADC Drug CDMO Service Product Life Cycle
3.3 Global ADC Drug CDMO Service Revenue Market Share by Company (2020-2025)
3.4 ADC Drug CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 ADC Drug CDMO Service Market Competitive Situation and Trends
3.6.1 ADC Drug CDMO Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest ADC Drug CDMO Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ADC Drug CDMO Service Value Chain Analysis
4.1 ADC Drug CDMO Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of ADC Drug CDMO Service Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global ADC Drug CDMO Service Market Porter's Five Forces Analysis
6 ADC Drug CDMO Service Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global ADC Drug CDMO Service Market by Type (2020-2025)
6.3 Global ADC Drug CDMO Service Market Size Growth Rate by Type (2021-2025)
7 ADC Drug CDMO Service Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global ADC Drug CDMO Service Market Size (M USD) by Application (2020-2025)
7.3 Global ADC Drug CDMO Service Market Size Growth Rate by Application (2021-2025)
8 ADC Drug CDMO Service Market Segmentation by Region
8.1 Global ADC Drug CDMO Service Market Size by Region
8.1.1 Global ADC Drug CDMO Service Market Size by Region
8.1.2 Global ADC Drug CDMO Service Market Size Market Share by Region
8.2 North America
8.2.1 North America ADC Drug CDMO Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe ADC Drug CDMO Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific ADC Drug CDMO Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America ADC Drug CDMO Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa ADC Drug CDMO Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Lonza Group
9.1.1 Lonza Group Basic Information
9.1.2 Lonza Group ADC Drug CDMO Service Product Overview
9.1.3 Lonza Group ADC Drug CDMO Service Product Market Performance
9.1.4 Lonza Group SWOT Analysis
9.1.5 Lonza Group Business Overview
9.1.6 Lonza Group Recent Developments
9.2 Merck KGaA
9.2.1 Merck KGaA Basic Information
9.2.2 Merck KGaA ADC Drug CDMO Service Product Overview
9.2.3 Merck KGaA ADC Drug CDMO Service Product Market Performance
9.2.4 Merck KGaA SWOT Analysis
9.2.5 Merck KGaA Business Overview
9.2.6 Merck KGaA Recent Developments
9.3 WuXi XDC
9.3.1 WuXi XDC Basic Information
9.3.2 WuXi XDC ADC Drug CDMO Service Product Overview
9.3.3 WuXi XDC ADC Drug CDMO Service Product Market Performance
9.3.4 WuXi XDC SWOT Analysis
9.3.5 WuXi XDC Business Overview
9.3.6 WuXi XDC Recent Developments
9.4 Abbvie
9.4.1 Abbvie Basic Information
9.4.2 Abbvie ADC Drug CDMO Service Product Overview
9.4.3 Abbvie ADC Drug CDMO Service Product Market Performance
9.4.4 Abbvie Business Overview
9.4.5 Abbvie Recent Developments
9.5 Piramal Pharma Solutions
9.5.1 Piramal Pharma Solutions Basic Information
9.5.2 Piramal Pharma Solutions ADC Drug CDMO Service Product Overview
9.5.3 Piramal Pharma Solutions ADC Drug CDMO Service Product Market Performance
9.5.4 Piramal Pharma Solutions Business Overview
9.5.5 Piramal Pharma Solutions Recent Developments
9.6 Catalent
9.6.1 Catalent Basic Information
9.6.2 Catalent ADC Drug CDMO Service Product Overview
9.6.3 Catalent ADC Drug CDMO Service Product Market Performance
9.6.4 Catalent Business Overview
9.6.5 Catalent Recent Developments
9.7 Sterling Pharma Solutions
9.7.1 Sterling Pharma Solutions Basic Information
9.7.2 Sterling Pharma Solutions ADC Drug CDMO Service Product Overview
9.7.3 Sterling Pharma Solutions ADC Drug CDMO Service Product Market Performance
9.7.4 Sterling Pharma Solutions Business Overview
9.7.5 Sterling Pharma Solutions Recent Developments
9.8 Axplora
9.8.1 Axplora Basic Information
9.8.2 Axplora ADC Drug CDMO Service Product Overview
9.8.3 Axplora ADC Drug CDMO Service Product Market Performance
9.8.4 Axplora Business Overview
9.8.5 Axplora Recent Developments
9.9 Aji Bio-Pharma
9.9.1 Aji Bio-Pharma Basic Information
9.9.2 Aji Bio-Pharma ADC Drug CDMO Service Product Overview
9.9.3 Aji Bio-Pharma ADC Drug CDMO Service Product Market Performance
9.9.4 Aji Bio-Pharma Business Overview
9.9.5 Aji Bio-Pharma Recent Developments
9.10 BSP Pharmaceuticals
9.10.1 BSP Pharmaceuticals Basic Information
9.10.2 BSP Pharmaceuticals ADC Drug CDMO Service Product Overview
9.10.3 BSP Pharmaceuticals ADC Drug CDMO Service Product Market Performance
9.10.4 BSP Pharmaceuticals Business Overview
9.10.5 BSP Pharmaceuticals Recent Developments
9.11 Cerbios-Pharma
9.11.1 Cerbios-Pharma Basic Information
9.11.2 Cerbios-Pharma ADC Drug CDMO Service Product Overview
9.11.3 Cerbios-Pharma ADC Drug CDMO Service Product Market Performance
9.11.4 Cerbios-Pharma Business Overview
9.11.5 Cerbios-Pharma Recent Developments
9.12 Goodwin Biotechnology
9.12.1 Goodwin Biotechnology Basic Information
9.12.2 Goodwin Biotechnology ADC Drug CDMO Service Product Overview
9.12.3 Goodwin Biotechnology ADC Drug CDMO Service Product Market Performance
9.12.4 Goodwin Biotechnology Business Overview
9.12.5 Goodwin Biotechnology Recent Developments
9.13 TOT Biopharm
9.13.1 TOT Biopharm Basic Information
9.13.2 TOT Biopharm ADC Drug CDMO Service Product Overview
9.13.3 TOT Biopharm ADC Drug CDMO Service Product Market Performance
9.13.4 TOT Biopharm Business Overview
9.13.5 TOT Biopharm Recent Developments
9.14 Huadong Medicine
9.14.1 Huadong Medicine Basic Information
9.14.2 Huadong Medicine ADC Drug CDMO Service Product Overview
9.14.3 Huadong Medicine ADC Drug CDMO Service Product Market Performance
9.14.4 Huadong Medicine Business Overview
9.14.5 Huadong Medicine Recent Developments
9.15 Innovent Biologics
9.15.1 Innovent Biologics Basic Information
9.15.2 Innovent Biologics ADC Drug CDMO Service Product Overview
9.15.3 Innovent Biologics ADC Drug CDMO Service Product Market Performance
9.15.4 Innovent Biologics Business Overview
9.15.5 Innovent Biologics Recent Developments
9.16 Shanghai Henlius Biotech
9.16.1 Shanghai Henlius Biotech Basic Information
9.16.2 Shanghai Henlius Biotech ADC Drug CDMO Service Product Overview
9.16.3 Shanghai Henlius Biotech ADC Drug CDMO Service Product Market Performance
9.16.4 Shanghai Henlius Biotech Business Overview
9.16.5 Shanghai Henlius Biotech Recent Developments
10 ADC Drug CDMO Service Market Forecast by Region
10.1 Global ADC Drug CDMO Service Market Size Forecast
10.2 Global ADC Drug CDMO Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe ADC Drug CDMO Service Market Size Forecast by Country
10.2.3 Asia Pacific ADC Drug CDMO Service Market Size Forecast by Region
10.2.4 South America ADC Drug CDMO Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of ADC Drug CDMO Service by Country
11 Forecast Market by Type and by Application (2026-2035)
11.1 Global ADC Drug CDMO Service Market Forecast by Type (2026-2035)
11.1.1 Global ADC Drug CDMO Service Market Size Forecast by Type (2026-2035)
11.2 Global ADC Drug CDMO Service Market Forecast by Application (2026-2035)
11.2.1 Global ADC Drug CDMO Service Market Size (M USD) Forecast by Application (2026-2035)
12 Conclusion and Key Findings